Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer

  • Javad Sharifi-Rad
  • , Cristina Quispe
  • , Zhazira Mukazhanova
  • , Ewa Knut
  • , Aknur Turgumbayeva
  • , Aliya Kipchakbayeva
  • , Gulnaz Seitimova
  • , Mohamad Fawzi Mahomoodally
  • , Devina Lobine
  • , Aaron Koay
  • , Jinfan Wang
  • , Helen Sheridan
  • , Gerardo Leyva-Gómez
  • , María L.Del Prado-Audelo
  • , Hernán Cortes
  • , Antonio Rescigno
  • , Paolo Zucca
  • , Oksana Sytar
  • , Muhammad Imran
  • , Célia F. Rodrigues
  • Natália Cruz-Martins, Halina Ekiert, Manoj Kumar, Ahmad Faizal Abdull Razis, Usman Sunusi, Ramla Muhammad Kamal, Agnieszka Szopa

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

79 Citas (Scopus)

Resumen

Resveratrol is a polyphenolic stilbene derivative widely present in grapes and red wine. Broadly known for its antioxidant effects, numerous studies have also indicated that it exerts anti-inflammatory and antiaging abilities and a great potential in cancer therapy. Regrettably, the oral administration of resveratrol has pharmacokinetic and physicochemical limitations such as hampering its effects so that effective administration methods are demanding to ensure its efficiency. Thus, the present review explores the published data on the application of resveratrol nanoformulations in cancer therapy, with the use of different types of nanodelivery systems. Mechanisms of action with a potential use in cancer therapy, negative effects, and the influence of resveratrol nanoformulations in different types of cancer are also highlighted. Finally, the toxicological features of nanoresveratrol are also discussed.

Idioma originalInglés
Número de artículo649395
PublicaciónFrontiers in Molecular Biosciences
Volumen8
DOI
EstadoPublicada - 1 sep. 2021
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Resveratrol-Based Nanoformulations as an Emerging Therapeutic Strategy for Cancer'. En conjunto forman una huella única.

Citar esto